Clinical Trial of Vagus Nerve Stimulation for Treatment of Refractory Epilepsy

NCT02378792 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2016-10-12

No results posted yet for this study

Summary

Evaluate the long-term clinical effectiveness and safety of the PINS vagus nerve stimulator to patients with refractory epilepsy.

Conditions

  • Refractory Epilepsy

Interventions

DEVICE

Vagus Nerve Stimulation

Vagus Nerve Stimulator

Sponsors & Collaborators

  • Beijing Tiantan Hospital

    collaborator OTHER
  • Beijing Pins Medical Co., Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2017-10-31
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02378792 on ClinicalTrials.gov